Among the skin tumors, malignant melanoma shows the highest metastasis rate (spread of the tumor). 90% of all deaths from skin tumors are due to this type of tumor. Malignant melanoma can arise spontaneously or develop from a birthmark (nevus); the risk for this increases significantly with the number of sunburns suffered in the course of life. The basis of the then developing tumor cells are genetic changes in these cells (mutations).
For the therapy of malignant melanoma, two drugs are approved as standard therapy. However, since these can only be given depending on the presence or absence of a mutation, molecular pathological diagnostics (including BRAF, NRAS) is essential. This is easily performed on tumor tissue and can be requested from us by your treating physician.